Norwich Ventures

Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its imaging technology surpasses light microscopy to analyze whether the tissues are fresh, frozen, or FFPE that enable healthcare providers to provide a diagnosis of cancer for improving human health.

McInnis Law is a law firm based in New York City, established in 1999. The firm specializes in various areas of legal practice, including false claims acts, Medicare billing fraud, pharmaceutical fraud, whistleblower retaliation, and healthcare fraud. Additionally, McInnis Law addresses issues related to ambulance billing fraud, defense contracting fraud, tax matters, customs duty, and anti-money laundering violations. Its comprehensive legal services cater to a diverse clientele, ensuring robust representation and advocacy in complex legal cases.

McInnis Law is a law firm based in New York City, established in 1999. The firm specializes in various areas of legal practice, including false claims acts, Medicare billing fraud, pharmaceutical fraud, whistleblower retaliation, and healthcare fraud. Additionally, McInnis Law addresses issues related to ambulance billing fraud, defense contracting fraud, tax matters, customs duty, and anti-money laundering violations. Its comprehensive legal services cater to a diverse clientele, ensuring robust representation and advocacy in complex legal cases.

Affera is a medical technology company dedicated to developing innovative solutions for the treatment of cardiac arrhythmia, a prevalent condition affecting millions of patients worldwide.

ReThink Medical, Inc. manufactures wrist-worn devices that measure, detect, and notify indicators of worsening heart failures. It detects and notifies worsening conditions of heart and heart failure weeks in advance that allows proper treatment preventing hospitalization. The company was founded in 2010 and is based in San Francisco, California. As of August 11, 2020, ReThink Medical, Inc. operates as a subsidiary of Terumo Corporation.

Founded in 2010, Pelvalon’s innovative new technology originated from Stanford University’s Biodesign program, a collaboration between the schools of Medicine and Engineering. The Biodesign program encourages the development of user-driven solutions to unmet medical needs, and they are proud to carry on the tradition of biomedical innovation. Pelvalon is privately held, and their investors include Norwich Ventures, a specialized venture capital firm focused on medical technology.

We are a Boston-based medical device company that manufactures minimally invasive surgical stapling solutions. With the highest standards in design engineering and smart manufacturing, our specialized team is committed to delivering disruptive innovation to health care providers and their patients.

Soffio Medical is a medical company that develops medical apparatus for respiratory diseases. The company is based in Boston, Massachusetts.

Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.

Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.

Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.

Vaxess Technologies, Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2011. It specializes in developing and commercializing silk biomaterial technologies aimed at improving vaccine delivery and storage. The company has created the MIMIX microneedle platform, which facilitates transdermal delivery of vaccines and therapies, and the MATRIX formulation and drying platform, which enhances the stability of vaccines, therapeutics, and diagnostic products. By utilizing a silk-derived protein, Vaxess enables vaccines to be stored and transported without refrigeration, thereby reducing distribution costs and increasing access to essential healthcare products globally.

Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.

Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.

Svelte Medical Systems, Inc. is a privately held company that specializes in the design and development of innovative balloon-expandable stents for patients undergoing percutaneous coronary interventions to treat atherosclerosis. Founded in 2007, the company is based in New Providence, New Jersey, and aims to address critical clinical issues in the coronary stent market, which is valued at approximately $5 billion. Svelte offers two primary products: the SLENDER Integrated Delivery System, a drug-eluting coronary stent-on-a-wire designed to facilitate transradial interventions, and the DIRECT Rapid Exchange System, which enhances direct stenting and high-pressure post-dilatations. Both systems utilize proprietary technologies to improve stent deliverability, reduce the need for additional guide wires and balloons, and ultimately enhance patient outcomes while minimizing procedure costs and risks.

Daktari Diagnostics, Inc., a healthcare solutions company, develops and provides portable point-of-care diagnostic platforms for disease management Worldwide. It offers Daktari Virology, a platform for HCV and HIV detection; Daktari InSight, a data management service that connects Daktari’s systems to its customers; and Daktari Sickle Cell, a solution that provides tests to identify infants with sickle cell disease from a drop of blood. The company was founded in 2008 and is based in Cambridge, Massachusetts.

Intelligent Bio-Systems, founded in 2005 by Drs. Steven J. Gordon and Jingyue Ju, focuses on the commercialization of advanced DNA sequencing systems. The company aims to enhance the speed and reduce the cost of generating sequence data, making its technology applicable in various fields, including research, clinical applications, and DNA resequencing. Its systems are particularly valuable for cancer and HIV/AIDS applications, allowing customers to achieve low-cost throughput sequencing while ensuring high-quality data. Dr. Gordon's background includes founding Intelligent Automation Systems, which contributed significantly to the Human Genome Project, while Dr. Ju is noted for her pioneering work on fluorescent energy transfer dyes that are integral to many electrophoresis-based sequencing technologies.

Rhythmia Medical, Inc. is an early-stage medical device company that specializes in developing solutions for the treatment of cardiac arrhythmia. The company is focused on creating a 3D mapping system designed to enhance catheter ablation procedures, which are commonly employed to treat tachy-arrhythmias, including atrial fibrillation. Rhythmia Medical aims to improve visualization and navigation during these procedures, thereby potentially increasing their effectiveness and safety for patients suffering from these heart conditions.

Syncro Medical Innovations, Inc. develops magnetically guided enteral feeding tubes. The company’s feeding tube contains magnetic field sensor at the distal end, electrically connected to a light indicator at the proximal end of the tube. Syncro Medical Innovations, Inc. was founded in 1998 and is based in Macon, Georgia.